CHG-2022-0067
Labeling Change for Neuravastatin. Container Closure Change for Neuravastatin — minor update. Impacts 1 markets and 4 variations.
Change Number
CHG-2022-0067
Type
Labeling Change
Product
Status
Failed
Owner
Dmitri Volkov
Initiated
2023-01-01
Description
Container Closure Change for Neuravastatin — minor update
Impacted Markets (1)
TR — Turkey
Impacted Modules
3.2.P4.2.15.3.5
Linked Variations (4)
| Variation # | Type | Application | Status | Submitted | Approved |
|---|---|---|---|---|---|
| TFDA-2024-0031-V331 | Type II | TFDA-2024-0031 | Draft | 2023-12-03 | — |
| HSA-2023-0032-V332 | Type IA | HSA-2023-0032 | Completed | 2023-06-27 | — |
| CDSCO-2022-0033-V333 | Type IA | CDSCO-2022-0033 | Draft | — | — |
| COFEPRIS-2021-0034-V334 | Type IA | COFEPRIS-2021-0034 | Failed | — | — |